Long term treatment of polymyalgia rheumatica with deflazacort.

OBJECTIVES--To evaluate the long term efficacy and tolerability of deflazacort, a corticosteroid reputed to have only minor side effects, in the treatment of polymyalgia rheumatica (PMR). METHODS--In a prospective open study, deflazacort was administered at an average initial dose of 21.8 mg/day for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cimmino, M A, Moggiana, G, Montecucco, C, Caporali, R, Accardo, S
Format: Artigo
Idioma:Inglês
Publicat: 1994
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1005333/
https://ncbi.nlm.nih.gov/pubmed/8017988
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars